Quick Overview
- IonQ delivered full-year 2025 revenue of $130 million, representing a 202% increase versus the prior year and marking a historic first for publicly traded quantum computing firms surpassing $100 million annually.
- Fourth quarter revenue reached $61.9 million, exceeding the company’s internal guidance midpoint by 55% and crushing Wall Street forecasts by more than 53%.
- The quantum computing firm reported fourth quarter EPS of $1.93, obliterating the consensus forecast of a -$0.48 loss per share — representing a 502% positive surprise.
- Management provided 2026 revenue guidance ranging from $225 million to $245 million while projecting adjusted EBITDA losses reaching $330 million due to aggressive investment spending.
- IONQ shares surged 7.35% during after-hours trading; analyst consensus stands at Moderate Buy with a mean price target of $70.25.
IonQ delivered a standout performance Wednesday evening. Following the release of fourth quarter and full-year 2025 financial results, shares rallied 7.35% in extended trading hours.
The financial performance commanded attention.
Annual 2025 revenue totaled $130 million, reflecting 202% growth compared to the previous year. This achievement positioned IonQ as the inaugural publicly traded quantum computing enterprise to surpass the $100 million annual revenue threshold.
The fourth quarter alone generated $61.9 million in revenue — exceeding the company’s internal guidance midpoint by 55% and surpassing Zacks consensus projections by more than 53%. Such magnitude of outperformance is rare across any industry, particularly within capital-intensive deep technology sectors.
Regarding profitability metrics, IonQ posted fourth quarter EPS of $1.93. Analyst consensus had anticipated a loss of $0.48 per share. The variance represents a 502% positive earnings surprise.
CEO Niccolo de Masi characterized 2025 as “a year of tremendous accomplishments and a strategic and financial inflection point” for the organization.
Notwithstanding the impressive results, IONQ shares have declined approximately 29.5% year-to-date, while the S&P 500 has advanced roughly 0.7% during the identical timeframe.
Strategic Initiatives and Future Direction
The organization isn’t merely capitalizing on previous success. IonQ provided 2026 revenue guidance spanning $225 million to $245 million — representing nearly double its 2025 benchmark.
The company recently unveiled a $1.8 billion acquisition agreement for SkyWater Technology, a specialized quantum chip manufacturing facility. This transaction would provide IonQ with domestic chip production capabilities, specifically addressing government and defense sector clients requiring U.S.-based supply chain infrastructure.
IonQ has also broadened its international collaboration with QuantumBasel, expanding the partnership value beyond $60 million across a four-year period, while targeting deployment of a 256-qubit sixth-generation system by the conclusion of 2026.
The enterprise is expanding beyond traditional quantum computing applications into networking, sensing, and security domains — establishing itself as a comprehensive quantum technology platform.
Investment Considerations and Challenges
IonQ continues operating at a loss. Management forecasts an adjusted EBITDA loss reaching $330 million throughout 2026 as capital deployment accelerates across research initiatives, workforce expansion, and manufacturing infrastructure.
Current consensus EPS projections for the upcoming quarter stand at -$0.40 on anticipated revenues of $38.61 million. Full fiscal year estimates project -$1.52 EPS on $198.77 million in revenues.
Zacks presently assigns the stock a #3 Hold rating, indicating expectations for market-aligned performance in the near term. This assessment may evolve as analysts refresh their financial models following management commentary.
Analyst Sentiment and Price Targets
Wall Street maintains a Moderate Buy consensus rating on IONQ, supported by seven Buy recommendations and three Hold ratings issued over the past three months.
The average analyst price target stands at $70.25, suggesting potential upside exceeding 100% from present trading levels.
These targets will likely undergo revision during upcoming days as research coverage incorporates the latest financial disclosure.





